Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): James LC;James LC; Tawfik DS
  • Source:
    Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2005 Sep 06; Vol. 102 (36), pp. 12730-5. Date of Electronic Publication: 2005 Aug 29.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0027-8424 (Print) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, DC : National Academy of Sciences
    • Subject Terms:
    • Abstract:
      Induced fit is a predominant phenomenon in protein-ligand interactions, yet it is invariably attributed without establishing the existence, let alone the structure, of the initial, low-affinity encounter complex. We determined the crystal structure of the encounter complex on the pathway of ligand binding by IgE antibody SPE7. We show that this complex is formed by a wide range of ligands that initially bind with identical affinity. Nonspecific ligands rapidly dissociate, whereupon the antibody isomerizes to a nonbinding isomer. Specific ligand complexes, however, slowly isomerize to give a high-affinity complex. This isomerization involves backbone and side-chain rearrangements of up to 14 A and the formation of specific hydrogen bonds. The postbinding conformational switch, combined with the prebinding isomerization to an energetically favorable nonbinding isomer, results in a "kinetic discrimination" mechanism that mediates selective binding, by a factor of >10(3), between highly related ligands that initially bind with the same affinity. This model may apply to proteins that bind multiple ligands in a specific manner or other proteins that, although capable of binding many ligands, are activated by only a few.
    • References:
      J Biol Chem. 2004 Jan 23;279(4):3042-9. (PMID: 14594809)
      Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1257-61. (PMID: 7877965)
      Adv Protein Chem. 2002;61:119-60. (PMID: 12461823)
      Protein Sci. 2003 Oct;12(10):2183-93. (PMID: 14500876)
      Mol Immunol. 2004 Feb;40(14-15):1027-31. (PMID: 15036906)
      Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):92-7. (PMID: 12518056)
      J Mol Biol. 1999 Oct 22;293(2):321-31. (PMID: 10550212)
      Nucleic Acids Res. 2000 Apr 15;28(8):1665-75. (PMID: 10734184)
      Structure. 1993 Oct 15;1(2):83-93. (PMID: 8069628)
      Curr Opin Struct Biol. 2004 Feb;14(1):104-9. (PMID: 15102456)
      Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2300-5. (PMID: 12591943)
      Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10370-4. (PMID: 7937957)
      Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11504-9. (PMID: 8876165)
      Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3803-8. (PMID: 15001706)
      Mol Pharmacol. 2004 Aug;66(2):356-63. (PMID: 15266027)
      Nat Struct Biol. 2003 Jun;10(6):482-8. (PMID: 12740607)
      Immunity. 2000 Nov;13(5):611-20. (PMID: 11114374)
      Nature. 1991 Aug 8;352(6335):530-2. (PMID: 1907716)
      Science. 2003 Feb 28;299(5611):1362-7. (PMID: 12610298)
      Immunol Today. 1998 Sep;19(9):395-404. (PMID: 9745202)
      Mol Immunol. 1991 Jun;28(6):641-54. (PMID: 1650428)
      J Mol Biol. 1993 Dec 20;234(4):946-50. (PMID: 8263940)
      Annu Rev Biochem. 1997;66:639-78. (PMID: 9242920)
      Science. 1992 Feb 21;255(5047):959-65. (PMID: 1546293)
      Curr Opin Struct Biol. 1994 Dec;4(6):857-67. (PMID: 7536111)
    • Grant Information:
      United Kingdom WT_ Wellcome Trust
    • Molecular Sequence:
      PDB 2BJM
    • Accession Number:
      0 (Anthracenes)
      0 (Antigens)
      0 (Ligands)
      37341-29-0 (Immunoglobulin E)
      FP0FJ7K744 (anthrone)
    • Publication Date:
      Date Created: 20050901 Date Completed: 20051101 Latest Revision: 20240412
    • Publication Date:
      20240412
    • Accession Number:
      PMC1200256
    • Accession Number:
      10.1073/pnas.0500909102
    • Accession Number:
      16129832